Diagnostics · Nasdaq

QuidelOrthoQDEL

Reported results from SEC filings: quarterly trend (up to twelve quarters) and annual results.

Quarterly results

Q3 2023 – Q2 2026

Revenue

Source: SEC EDGAR XBRL (10-Q, 10-K), latest filing included August 7, 2026. Some quarterly values (typically Q4 and quarterly cash flow) are derived from reported year-to-date totals.

Operating income and net income

Operating incomeNet income

Source: SEC EDGAR XBRL (10-Q, 10-K), latest filing included August 7, 2026. Some quarterly values (typically Q4 and quarterly cash flow) are derived from reported year-to-date totals.

Cash flow

Operating cash flowCapital expenditureFree cash flow

Source: SEC EDGAR XBRL (10-Q, 10-K), latest filing included August 7, 2026. Some quarterly values (typically Q4 and quarterly cash flow) are derived from reported year-to-date totals. FCF = operating cash flow − capital expenditure.

Margins

Operating marginNet marginFCF margin

Annual results

FY2021 – FY2025

Annual results

RevenueOperating incomeFree cash flow

Source: SEC EDGAR XBRL (10-K), latest filing included August 7, 2026.

Margins

Operating marginNet marginFCF margin

Source: SEC EDGAR XBRL (10-K), latest filing included August 7, 2026.

Quarterly data (USD millions)

	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Revenue	744	743	711	637	727	708	693	614	700	724	620	631
Operating income	26	40	−1,758	−118	15	−100	33	−181	−705	−66	−32	−22
Net income	−13	7	−1,706	−148	−20	−178	−13	−255	−733	−131	−92	−93
Operating cash flow	42	80	−1	−98	118	64	66	−47	−46	132	−33	−111
Capital expenditure	43	49	66	35	46	47	56	38	49	45	34	26
Free cash flow	−2	32	−67	−133	71	16	9	−84	−95	87	−67	−136
Operating margin %	3.5	5.4	−247.3	−18.4	2.1	−14.2	4.7	−29.4	−100.7	−9.2	−5.1	−3.5
Net margin %	−1.7	0.9	−239.9	−23.2	−2.7	−25.2	−1.8	−41.6	−104.7	−18.1	−14.8	−14.7
FCF margin %	−0.3	4.3	−9.4	−20.9	9.8	2.3	1.4	−13.7	−13.5	12.0	−10.8	−21.6

Annual data (USD millions)

	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,699	3,266	2,998	2,783	2,730
Operating income	906	844	139	−1,961	−919
Net income	704	549	−10	−2,052	−1,132
Operating cash flow	806	885	280	83	105
Capital expenditure	293	141	209	195	188
Free cash flow	513	744	71	−112	−83
Operating margin %	53.3	25.8	4.6	−70.5	−33.7
Net margin %	41.5	16.8	−0.3	−73.7	−41.5
FCF margin %	30.2	22.8	2.4	−4.0	−3.0

Notes

Operating cash flow minus purchases of property, plant and equipment (capital expenditure), as reported.
QuidelOrtho reports on a 52/53-week fiscal year ending on the Sunday closest to December 31.

Data files: financials.json

QuidelOrthoQDEL

Quarterly results

Annual results

Quarterly data (USD millions)

Annual data (USD millions)

Notes

Research

Site